Ulipristal acetate: all 52 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Mammogram Pretreatment With Ulipristal AcetateRecruitingNCT07434128Phase 2
- Disparities in Emergency Contraceptive Metabolism Dictate EfficacyRecruitingNCT05674513Phase 4
- Ulipristal Acetate for Use in Early Pregnancy LossCompletedNCT05216952Phase 2Results posted
- Intervention to End Recurrent Unscheduled Bleeding TrialCompletedNCT03118297Phase 3Results posted
- Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPACompletedNCT02859337Phase 4Results posted
- EC PK in Women With Normal and Obese BMICompletedNCT02689804Phase 4Results posted
- Impact of Combined Hormonal Contraceptives on UPACompletedNCT02577601Phase 4Results posted
- A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147197Phase 3Results posted
- A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147158Phase 3Results posted
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01629563Phase 3Results posted
- PGL4001 Versus GnRH-agonist in Uterine MyomasCompletedNCT00740831Phase 3Results posted
- Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency ContraceptionCompletedNCT00551616Phase 3Results posted
- Safety and Efficacy of CDB-2914 for Emergency ContraceptionCompletedNCT00411684Phase 3Results posted
- Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914CompletedNCT00290251Phase 2Results posted
- Use of Ulipristal Acetate in Induction of Second Trimester Missed AbortionCompletedNCT04989400Phase 4
- Ulipristal Acetate in Symptomatic Uterine FibroidTerminatedNCT04132349Phase 4
- Advance Provision of Medication AbortionWithdrawnNCT03829696Phase 4
- Ulipristal Acetate for Cervical PreparationCompletedNCT03802149Early Phase 1
- Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kgTerminatedNCT03537768Phase 4
- On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak FertilityCompletedNCT03354117Phase 1
- Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With AdenomyosisWithdrawnNCT03325868Phase 4
- Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a ContraceptiveWithdrawnNCT03296098Phase 2
- Ulipristal Versus Placebo for Women With Bleeding Induced by MirenaStatus unknownNCT03186586Phase 4
- Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual BleedingWithdrawnNCT03027973Phase 1
- Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell ProliferationCompletedNCT02922127Phase 1
- Ulipristal Use in Chinese PopulationTerminatedNCT02825719Phase 4
- Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female SubjectsCompletedNCT02634437Phase 1
- IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF FailureStatus unknownNCT02601196Phase 4
- Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1ATerminatedNCT02600286Phase 2
- Adenomyosis and Ulipristal AcetateCompletedNCT02587000Phase 2
- A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling WomenStatus unknownNCT02451826Phase 1/2
- Endometrial Preparation Before Operative Hysteroscopy in Premenopausal WomenStatus unknownNCT02440750Phase 4
- Ulipristal Acetate 10 mg and Asisted ReproductionTerminatedNCT02425878Phase 3
- Breast Cancer - Anti-Progestin Prevention Study 1CompletedNCT02408770Phase 2
- Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular LeiomyomasStatus unknownNCT02361905Phase 4
- The Effect of Ulipristal Acetate (UPA) on Women Ovarian ReserveStatus unknownNCT02361892Phase 4
- Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine LeiomyomaStatus unknownNCT02361879Phase 4
- Ulipristal Acetate Versus GnRH Analogue and Myometrial PreservationStatus unknownNCT02357563Phase 4
- Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 DaysCompletedNCT01953679Phase 2
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01642472Phase 3
- Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine LeiomyomaWithdrawnNCT01553123Phase 3
- CDB-2914 for Abnormal Uterine Bleeding in Premenopausal WomenWithdrawnNCT01493791Early Phase 1
- Ulipristal Acetate on Progesterone Levels and Glycodelin-A Endometrial PatternStatus unknownNCT01391845Not applicable
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)CompletedNCT01252069Phase 3
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01156857Phase 3
- Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) SurgeCompletedNCT01107093Phase 2
- Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914CompletedNCT00791297Phase 2
- Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914CompletedNCT00456924Phase 2
- Efficacy Trial of CDB 2914 for Emergency ContraceptionCompletedNCT00271583Phase 2/3
- Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor AntagonistCompletedNCT00044876Phase 2
- Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914CompletedNCT00041899Phase 1
- Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of MenopauseCompletedNCT00009659Phase 2